Details the research study by Stanford University for this treatment method of breast cancer.

Details information on clinical studies for this condition that use the Telik firm's drug-agent TLK286.

Outlines aspects of this research study for skin cancer with the agent Verteporfin.

Biotech firm is seeking clinical participants for the evaluation of their blood test to detect breast cancer.

This UK research inquiry will evaluate over 100,000 subjects to help determine causes of breast cancer.

Oncology personnel offer recommendations for your condition. Service fee required.

Information about an NCI-funded program which facilitates participation in phase III clinical trials.

Comprehensive searchable registry presented by the U.S. National Cancer Institute.

A interactive resource offering patients and physicians clinical trial information.

Details the working of a clinical trials matching program.

Overview guidance as presented by a cancer survivor.

Research programs and current studies at the City of Hope cancer center in Duarte, California.

Discussion of chronic myelogenous leukemia by the Antigenics firm and its cancer vaccine trial for AG-858.

Resource for clinical trials and research. Information about experimental anticancer drugs, chemotherapy treatment and cooperative groups.

Outlines the terms and progress of a research study related to cancer risk communication in hereditary breast, ovarian and colorectal cancers.

Provides a clinical trial service matching and referral service for cancer patients. Includes contact details.

General resource by the U.S. Food and Drug Administration.

Phase III clinical study with Transferrin-CRM107 for this type of brain tumor.

Evaluates innovative and promising methods and approaches to cancer treatment through clinical studies.

Allows users to search a database of research projects including clinical trials as supported by major US and UK funding organizations.

Phase II clinical trial for hormone-refractory disease by the MGI Pharma company.

Information about the use of Oncophage, an experimental vaccine treatment for this condition by the pharmaceutical firm, Antigenics.

Clinical research involving the use of the anti-cancer drug bexarotene.

Presents the work of Dr. David Christiani and his team at the Harvard School of Public Health on risk factors and treatment response.

Overview information as presented by this Houston, Texas hospital and research complex, as well as listings of ongoing institutional studies.

Discussion of melanoma by Antigenics, Inc. in the context of its vaccine therapy trials.

Information presented by a UK non-profit organization about a clinical trial for pleural mesothelioma.

General information from this University of Pennsylvania source.

Outlines a current study about the influence of diet and physical activity. Conducted by the University of South Carolina and the Palmetto Health system.

This firm is soliciting participants to a Phase II clinical trial with the hormonal agent toremifene for use in prostatic intraepithelial neoplasia which is thought to be a precursor condition to prostate cancer.

Gives details about the clinical trial involving the use of Herceptin as adjuvant therapy in HER2-positive patients with primary breast cancer. This resource is designed for use by patients and investigators.

Describes a scientific inquiry on the genetic and environmental risk factors for breast cancer.

Washington University institution seeks patient volunteers for a genetic research project.

Research study underway for newly diagnosed women living in the greater Los Angeles area.

Description and trials listing related to basic science, clinical research, epidemiology control and patient care programs at this San Francisco, California institution.

General information as presented by this support organization with links to trial finder services for prostate cancer.

Gives information on cancer research including current trials, centers, events, meetings, and links.